What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals.

Autor:	de Haan L; Department of Internal Medicine, Flevo Hospital, Almere, The Netherlands lr.de.haan@nwz.nl.; Department of Internal Medicine, Medical Centre Alkmaar, Alkmaar, The Netherlands., Ten Wolde M; Department of Internal Medicine, Flevo Hospital, Almere, The Netherlands., Beudel M; Department of Neurology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Olde Engberink RHG; Center of Experimental and Molecular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Appelman B; Center of Experimental and Molecular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Haspels-Hogervorst EK; Department of Intensive Care, Martini Hospital, Groningen, The Netherlands., Rusch D; Department of Intensive Care, Martini Hospital, Groningen, The Netherlands., Gritters van den Oever NC; Department of Intensive Care, Treant Zorggroep, Hoogeveen, The Netherlands., Simsek S; Department of Internal Medicine, Medical Centre Alkmaar, Alkmaar, The Netherlands., Paternotte N; Department of Pulmonology, Northwest Hospital Group, Alkmaar, The Netherlands., van den Bergh JP; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands., Wyers CE; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands., de Kruif MD; Department of Pulmonary Medicine, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands., Dormans T; Department of Intensive Care, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands., Moeniralam H; Department of Internal Medicine, Sint Antonius Hospital, Nieuwegein, The Netherlands., Bokhizzou N; Department of Internal Medicine, Bovenij Hospital, Amsterdam, The Netherlands., Brinkman K; Department of Internal Medicine, OLVG, Amsterdam, The Netherlands., Douma R; Department of Internal Medicine, Flevo Hospital, Almere, The Netherlands.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2023 Nov 14; Vol. 13 (11), pp. e075232. Date of Electronic Publication: 2023 Nov 14.
DOI:	10.1136/bmjopen-2023-075232
Abstrakt:	Objectives: To evaluate the relationship among dysnatraemia at hospital presentation and duration of admission, risk of intensive care unit (ICU) admission and all-cause mortality and to assess the underlying pathophysiological mechanism of hyponatraemia in patients with COVID-19. Our hypothesis is that both hyponatraemia and hypernatraemia at presentation are associated with adverse outcomes. Design: Observational study. Setting: Secondary care; 11 Dutch hospitals (2 university and 9 general hospitals). Participants: An analysis was performed within the retrospective multicentre cohort study COVIDPredict. 7811 patients were included (60% men, 40% women) between 24 February 2020 and 9 August 2022. Patients who were ≥18 years with PCR-confirmed COVID-19 or CT with COVID-19 reporting and data system score≥4 and alternative diagnosis were included. Patients were excluded when serum sodium levels at presentation were not registered in the database or when they had been transferred from another participating hospital. Outcome Measures: We studied demographics, medical history, symptoms and outcomes. Patients were stratified according to serum sodium concentration and urinary sodium excretion. Results: Hyponatraemia was present in 2677 (34.2%) patients and hypernatraemia in 126 (1.6%) patients. Patients with hyponatraemia presented more frequently with diarrhoea, lower blood pressure and tachycardia. Hyponatraemia was, despite a higher risk for ICU admission (OR 1.27 (1.11-1.46; p<0.001)), not associated with mortality or the risk for intubation. Patients with hypernatraemia had higher mortality rates (OR 2.25 (1.49-3.41; p<0.001)) and were at risk for ICU admission (OR 2.89 (1.83-4.58)) and intubation (OR 2.95 (1.83-4.74)). Conclusions: Hypernatraemia at presentation was associated with adverse outcomes in patients with COVID-19. Hypovolaemic hyponatraemia was found to be the most common aetiology of hyponatraemia. Hyponatraemia of unknown aetiology was associated with a higher risk for ICU admission and intubation and longer duration of admission. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu